These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 17927503)
1. Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins. Hao X; Sun Y; Yang CS; Bose M; Lambert JD; Ju J; Lu G; Lee MJ; Park S; Husain A; Wang S Nutr Cancer; 2007; 59(1):62-9. PubMed ID: 17927503 [TBL] [Abstract][Full Text] [Related]
2. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Ju J; Hong J; Zhou JN; Pan Z; Bose M; Liao J; Yang GY; Liu YY; Hou Z; Lin Y; Ma J; Shih WJ; Carothers AM; Yang CS Cancer Res; 2005 Nov; 65(22):10623-31. PubMed ID: 16288056 [TBL] [Abstract][Full Text] [Related]
4. Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E). Fu H; He J; Mei F; Zhang Q; Hara Y; Ryota S; Lubet RA; Chen R; Chen DR; You M Cancer Prev Res (Phila); 2009 Jun; 2(6):531-7. PubMed ID: 19470785 [TBL] [Abstract][Full Text] [Related]
5. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Lu G; Liao J; Yang G; Reuhl KR; Hao X; Yang CS Cancer Res; 2006 Dec; 66(23):11494-501. PubMed ID: 17145898 [TBL] [Abstract][Full Text] [Related]
8. Green Tea Polyphenols Inhibit Colorectal Tumorigenesis in Azoxymethane-Treated F344 Rats. Hao X; Xiao H; Ju J; Lee MJ; Lambert JD; Yang CS Nutr Cancer; 2017; 69(4):623-631. PubMed ID: 28323438 [TBL] [Abstract][Full Text] [Related]
9. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate. James KD; Forester SC; Lambert JD Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115 [TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Lu G; Xiao H; You H; Lin Y; Jin H; Snagaski B; Yang CS Clin Cancer Res; 2008 Aug; 14(15):4981-8. PubMed ID: 18676773 [TBL] [Abstract][Full Text] [Related]
11. Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies. Yang CS; Lee MJ; Chen L Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):83-9. PubMed ID: 9950244 [TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995 [TBL] [Abstract][Full Text] [Related]
13. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate. Lambert JD; Kwon SJ; Ju J; Bose M; Lee MJ; Hong J; Hao X; Yang CS Carcinogenesis; 2008 Oct; 29(10):2019-24. PubMed ID: 18684728 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3-gallate and fish oil. Bose M; Hao X; Ju J; Husain A; Park S; Lambert JD; Yang CS J Agric Food Chem; 2007 Sep; 55(19):7695-700. PubMed ID: 17696481 [TBL] [Abstract][Full Text] [Related]
15. Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J Mice. Zhang Q; Fu H; Pan J; He J; Ryota S; Hara Y; Wang Y; Lubet RA; You M Pharm Res; 2010 Jun; 27(6):1066-71. PubMed ID: 20112129 [TBL] [Abstract][Full Text] [Related]
16. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Xiao H; Hao X; Simi B; Ju J; Jiang H; Reddy BS; Yang CS Carcinogenesis; 2008 Jan; 29(1):113-9. PubMed ID: 17893236 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of a green tea polyphenol, epigallocatechin-3-gallate, against sevoflurane-induced neuronal apoptosis involve regulation of CREB/BDNF/TrkB and PI3K/Akt/mTOR signalling pathways in neonatal mice. Ding ML; Ma H; Man YG; Lv HY Can J Physiol Pharmacol; 2017 Dec; 95(12):1396-1405. PubMed ID: 28679060 [TBL] [Abstract][Full Text] [Related]
18. Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup Gu Y; Moroy G; Paul JL; Rebillat AS; Dierssen M; de la Torre R; Cieuta-Walti C; Dairou J; Janel N Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092951 [TBL] [Abstract][Full Text] [Related]
19. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. Yang F; de Villiers WJ; McClain CJ; Varilek GW J Nutr; 1998 Dec; 128(12):2334-40. PubMed ID: 9868178 [TBL] [Abstract][Full Text] [Related]
20. Cancer inhibition by green tea. Fujiki H; Suganuma M; Okabe S; Sueoka N; Komori A; Sueoka E; Kozu T; Tada Y; Suga K; Imai K; Nakachi K Mutat Res; 1998 Jun; 402(1-2):307-10. PubMed ID: 9675322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]